DALLAS and NEW YORK, Oct. 11 Access Pharmaceuticals, Inc. (OTC Bulletin Board: ACCP), a biopharmaceutical company specializing in products for cancer and supportive care, announced the highlights from ...
DALLAS and NEW YORK, July 14, 2011 /PRNewswire/ -- ACCESS PHARMACEUTICALS, INC. (OTCBB: ACCP), a biopharmaceutical company leveraging its proprietary drug-delivery platforms to develop treatments in ...
DALLAS and NEW YORK, Feb. 16, 2012 /PRNewswire/ -- ACCESS PHARMACEUTICALS, INC. (OTCBB: ACCP), a biopharmaceutical company leveraging its proprietary drug-delivery platforms to develop treatments in ...
WALTHAM, Mass., April 28, 2014 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (Nasdaq:AMAG) today announced that the publication of data from a multi-institutional trial of MuGard has been featured in ...
DALLAS, June 22 /PRNewswire-FirstCall/ -- ACCESS PHARMACEUTICALS, INC. (OTC Bulletin Board: ACCP) today announced the clinical results of MuGard(TM) at the 18th ...
DALLAS and NEW YORK, June 27, 2013 /PRNewswire/ -- ACCESS PHARMACEUTICALS, INC. (OTCBB: ACCP), an emerging biopharmaceutical company, announced that Dr. Ron R. Allison of Carolina Radiation Medicine, ...
DALLAS, July 29 ACCESS PHARMACEUTICALS, INC. (OTC Bulletin Board: ACCP), announced today that it is evaluating strategic options for the commercialization of MuGard in North America. MuGard is an FDA ...
MuGard is a novel; ready-to-use mucoadhesive oral wound rinse and coating for the management of oral mucositis, a debilitating side effect of many anticancer treatments. Up to 40% of all patients ...
Salesforce Management: At the end of 2010, Access commenced training of third-party MuGard representatives on the product, the oral mucositis condition and sales strategy. These reps initiated a broad ...
DALLAS, Dec. 13 /PRNewswire-FirstCall/ -- ACCESS PHARMACEUTICALS, INC. (OTC Bulletin Board: ACCP) announced today that it had received 510(k) clearance from the Food ...
Access Pharmaceuticals announced that it is evaluating options for the commercialization of MuGard, a mucoadhesive oral wound rinse for managing oral mucositis, in North America. Earlier this year, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results